UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone

The journal of clinical psychiatry, 2009-04, Vol.70 (4), p.487-499

2009

Volltextzugriff (PDF)

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm

JAMA psychiatry (Chicago, Ill.), 2015-05, Vol.72 (5), p.438

2015

Volltextzugriff (PDF)

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

JAMA : the journal of the American Medical Association, 2009-10, Vol.302 (16), p.1765

2009

Volltextzugriff (PDF)

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic

The journal of clinical psychiatry, 2003-10, Vol.64 (10), p.1250-1257

2003

Volltextzugriff (PDF)

A systematic review of medical treatments for children with autism spectrum disorders

Pediatrics (Evanston), 2011-05, Vol.127 (5), p.e1312-e1321

2011

Volltextzugriff (PDF)

Antipsychotics for treatment of delirium in hospitalised non-ICU patients

Cochrane database of systematic reviews, 2018-06, Vol.6 (6), p.CD005594

2018

Volltextzugriff (PDF)

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

JAMA psychiatry (Chicago, Ill.), 2016-09, Vol.73 (9), p.938

2016

Volltextzugriff (PDF)

Risk of Mortality Among Individual Antipsychotics in Patients With Dementia

The American journal of psychiatry, 2012-01, Vol.169 (1), p.71-79

2012

Volltextzugriff (PDF)

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

The New England journal of medicine, 2005-09, Vol.353 (12), p.1209-1223

2005

Volltextzugriff (PDF)

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone

The international journal of neuropsychopharmacology, 2020-04, Vol.23 (4), p.217-229

2020

Volltextzugriff (PDF)

Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study

BMJ, 2012-02, Vol.344 (feb23 2), p.e977-e977

International edition, 2012

Volltextzugriff (PDF)

The side effect profile of Clozapine in real world data of three large mental health hospitals

PloS one, 2020-12, Vol.15 (12), p.e0243437

2020

Volltextzugriff (PDF)

A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes

Schizophrenia bulletin, 2015-11, Vol.41 (6), p.1227-1236

2015

Volltextzugriff (PDF)

Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study

JAMA psychiatry (Chicago, Ill.), 2015-09, Vol.72 (9), p.927

2015

Volltextzugriff (PDF)

AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study

Schizophrenia research, 2016-04, Vol.172 (1-3), p.152-157

2016

Volltextzugriff (PDF)

Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization

Journal of the American Academy of Child and Adolescent Psychiatry, 2021-02, Vol.60 (2), p.236-251

2021

Volltextzugriff (PDF)

Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety

Journal of clinical psychopharmacology, 2016-06, Vol.36 (3), p.244-252

Uguz, Faruk

2016

Volltextzugriff (PDF)

Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia

Psychopharmacology, 2014, Vol.231 (2), p.319-325

2014

Volltextzugriff (PDF)

Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study

Journal of the American Academy of Child and Adolescent Psychiatry, 2023-09, Vol.62 (9), p.1021-1050

2023

Volltextzugriff (PDF)

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

The New England journal of medicine, 2006-10, Vol.355 (15), p.1525-1538

2006

Volltextzugriff (PDF)

Falls and fractures with atypical antipsychotic medication use: a population-based cohort study

JAMA internal medicine, 2015-03, Vol.175 (3), p.450

2015

Volltextzugriff (PDF)

Association between voriconazole-induced visual hallucination and dopamine in an analysis of the food and drug administration (FDA) adverse event reporting system database

Scientific reports, 2024-05, Vol.14 (1), p.12519-5, Article 12519

2024

Volltextzugriff (PDF)

Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review

The journal of clinical psychiatry, 2009-07, Vol.70 (7), p.1041-1050

2009

Volltextzugriff (PDF)

Into a Deeper Understanding of CYP2D6's Role in Risperidone Monotherapy and the Potential Side Effects in Schizophrenia Spectrum Disorders

International journal of molecular sciences, 2024-06, Vol.25 (12), p.6350

2024

Volltextzugriff (PDF)

Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels

Psychopharmacology, 2016-05, Vol.233 (9), p.1695-1705

2016

Volltextzugriff (PDF)

1 – 25 von 1.766

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.698)
Mit Volltextzugriff
(1.138)

Publikationsform

Artikel
(1.766)

Sprache

11 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.734)
Science & Technology
(1.521)
Life Sciences & Biomedicine
(1.508)
Antipsychotic Agents - Adverse Effects
(1.485)
Risperidone - Adverse Effects
(1.461)
Male
(1.381)
Psychiatry
(1.185)
Adult
(1.097)
Risperidone - Therapeutic Use
(1.004)
Antipsychotic Agents - Therapeutic Use
(975)
Middle Aged
(797)
Schizophrenia - Drug Therapy
(797)
Biological And Medical Sciences
(665)
Medical Sciences
(660)
Risperidone
(658)
Pharmacology & Pharmacy
(610)
Pharmacology. Drug Treatments
(599)
Schizophrenia
(516)
Adolescent
(505)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone

Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic

A systematic review of medical treatments for children with autism spectrum disorders

Antipsychotics for treatment of delirium in hospitalised non-ICU patients

Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

Risk of Mortality Among Individual Antipsychotics in Patients With Dementia

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone

Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study

The side effect profile of Clozapine in real world data of three large mental health hospitals

A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes

Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study

AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study

Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization

Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety

Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia

Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

Falls and fractures with atypical antipsychotic medication use: a population-based cohort study

Association between voriconazole-induced visual hallucination and dopamine in an analysis of the food and drug administration (FDA) adverse event reporting system database

Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review

Into a Deeper Understanding of CYP2D6's Role in Risperidone Monotherapy and the Potential Side Effects in Schizophrenia Spectrum Disorders

Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels

Aktive Filter

Suchergebnisse filtern